Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-11, Stock:LLY, The news for the past five days is as follows:
2019-02-04: NEWS1: Eli Lilly Is Trading Strong Ahead of Earnings on Wednesday.NEWS2: Teva Gains Positive CHMP Opinion for Migraine Drug Ajovy.NEWS3: Teva Gains Positive CHMP Opinion for Migraine Drug Ajovy.NEWS4: 5 of the Best Biotech Stocks to Buy Now.NEWS5: Teva Gains Positive CHMP Opinion for Migraine Drug Ajovy.NEWS6: Lilly Announces Top-Line Phase 3 Results for Baricitinib in Patients with Moderate to Severe Atopic Dermatitis.NEWS7: Lilly : Baricitinib Meets Primary Endpoint In BREEZE-AD1 And BREEZE-AD2.NEWS8: Lilly : Baricitinib Meets Primary Endpoint In BREEZE-AD1 And BREEZE-AD2.
2019-02-05: NEWS1: Pre-Market Earnings Report for February 6, 2019 :  LLY, GM, BSX, REGN, HUM, CTSH, CMI, GSK, FDC, TTWO, BIP, JEC.NEWS2: Pre-Market Earnings Report for February 6, 2019 :  LLY, GM, BSX, REGN, HUM, CTSH, CMI, GSK, FDC, TTWO, BIP, JEC.NEWS3: Sanofi's Myeloma Candidate Meets Goal in Phase III Study.NEWS4: Sanofi's Myeloma Candidate Meets Goal in Phase III Study.NEWS5: Roche Submits sBLA to FDA for Label Expansion of Kadcyla.NEWS6: Roche Submits sBLA to FDA for Label Expansion of Kadcyla.NEWS7: Merck's Keytruda Clinches CHMP Nod for Difficult Lung Cancer.NEWS8: Merck's Keytruda Clinches CHMP Nod for Difficult Lung Cancer.NEWS9: Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies.NEWS10: Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies.NEWS11: Allergan Stock Falls as FDA OK's Botox Rival for Frown Lines.NEWS12: Allergan Stock Falls as FDA OK's Botox Rival for Frown Lines.NEWS13: Sanofi's Myeloma Candidate Meets Goal in Phase III Study.NEWS14: Merck's Keytruda Clinches CHMP Nod for Difficult Lung Cancer.NEWS15: Roche Submits sBLA to FDA for Label Expansion of Kadcyla.NEWS16: Allergan Stock Falls as FDA OK's Botox Rival for Frown Lines.NEWS17: Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies.NEWS18: The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results.
2019-02-06: NEWS1: Eli Lilly & Co (LLY) Q4 2019 Earnings Conference Call Transcript.NEWS2: Eli Lilly & Co (LLY) Q4 2019 Earnings Conference Call Transcript.NEWS3: Stocks End Lower as Wall Street Gets No Boost From State of the Union.NEWS4: Eli Lilly Misses Q4 Earnings, Cuts 2019 Outlook After Loxo Oncology Deal.NEWS5: This Top Pharma Stock Undercut A Buy Point On Its Earnings Lag.NEWS6: Stocks end lower amid mixed corporate earnings.NEWS7: Stocks Trade Lower as Wall Street Gets No Boost From State of the Union.NEWS8: Eli Lilly & Co (LLY) Q4 2019 Earnings Conference Call Transcript.NEWS9: This Top Pharma Stock Undercut A Buy Point On Its Earnings Lag.NEWS10: Eli Lilly Stock Falls Because 2019 Isn’t 2018.NEWS11: Stocks Mostly Lower as Wall Street Gets No Boost From State of the Union.NEWS12: Lilly (LLY) Lags Q4 Earnings, Lowers 2019 View, Stock Down.NEWS13: Lilly (LLY) Lags Q4 Earnings, Lowers 2019 View, Stock Down.NEWS14: Eli Lilly backs U.S. proposal on drug rebates to lower costs.NEWS15: Eli Lilly cuts 2019 forecast on trial failure, Loxo deal.NEWS16: Eli Lilly (LLY) Lags Q4 Earnings, Tops Sales, Cuts 2019 View.NEWS17: Eli Lilly (LLY) Lags Q4 Earnings, Tops Sales, Cuts 2019 View.NEWS18: Dow Falls as Wall Street Gets No Boost From State of the Union.NEWS19: Lilly (LLY) Lags Q4 Earnings, Lowers 2019 View, Stock Down.NEWS20: Eli Lilly (LLY) Lags Q4 Earnings, Tops Sales, Cuts 2019 View.NEWS21: The Daily Biotech Pulse: Paratek Launches Antibiotic In US, Eli Lilly Earnings, Catabasis Offering.NEWS22: Small-Caps Are Making Big Moves in This Technically Extended Market.NEWS23: Stocks making the biggest moves premarket: Eli Lilly, Humana, Disney, Spotify & more.NEWS24: [$$] Eli Lilly cuts 2019 outlook after trial failure and Loxo deal.NEWS25: Lilly lowers 2019 forecast due to drug failure, pending deal.NEWS26: Lilly lowers 2019 forecast due to drug failure, pending deal.NEWS27: Earnings Reaction History: Eli Lilly & Co., 54.5% Follow-Through Indicator, 2.5% Sensitive.NEWS28: Earnings Reaction History: Eli Lilly & Co., 54.5% Follow-Through Indicator, 2.5% Sensitive.NEWS29: [$$] Eli Lilly Swings to Profit in Latest Quarter.NEWS30: Eli Lilly Earnings Miss, Forecast Light; Stock Flirts With Buy Point.NEWS31: Eli Lilly Earnings Miss, EPS Guidance Light; Stock Threatens To Undercut Buy Point.NEWS32: Eli Lilly&apos;s stock falls after profit miss, lowered outoook.NEWS33: Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology.NEWS34: Stocks - Snap Soars in Premarket, Electronic Arts, Take-Two, Spotify Plunge.NEWS35: Eli Lilly Lowers FY19 Outlook - Quick Facts.NEWS36: Eli Lilly Lowers FY19 Outlook - Quick Facts.NEWS37: Stocks - U.S. Futures Inch Down Ahead of GM Earnings.NEWS38: Eli Lilly Earnings miss, Revenue beats In Q4.NEWS39: Eli Lilly And Co. Q4 18 Earnings Conference Call At 9:00 AM ET.NEWS40: Eli Lilly And Co. Q4 18 Earnings Conference Call At 9:00 AM ET.NEWS41: Top 5 Things to Know in The Market on Wednesday.
2019-02-07: NEWS1: Edited Transcript of LLY earnings conference call or presentation 6-Feb-19 2:00pm GMT.NEWS2: Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth.NEWS3: Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth.NEWS4: Stock Market News For Feb 7, 2019.NEWS5: Stock Market News For Feb 7, 2019.NEWS6: Stock Market News For Feb 7, 2019.NEWS7: 5 Reasons Eli Lilly Investors Look Can Look Past Lartruvo's Failure.NEWS8: 5 Reasons Eli Lilly Investors Look Can Look Past Lartruvo's Failure.NEWS9: Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth.NEWS10: 5 Reasons Eli Lilly Investors Look Can Look Past Lartruvo&apos;s Failure.
2019-02-08: NEWS1: Teva (TEVA) to Report Q4 Earnings: What's in the Cards?.NEWS2: Mattel soars while Hasbro and Goodyear tumble.NEWS3: Incyte Down as FDA Extends Review Period of Jakafi for GVHD.NEWS4: 7 Fundamentally Sound Dividend Stocks to Buy.NEWS5: Eli Lilly and Company -- Moody's: Lilly's animal health divestiture will reduce scale and diversity.NEWS6: Lilly to Participate in Guggenheim Healthcare Talks Idea Forum.NEWS7: Eli Lilly to Unload Its Remaining Stock in Elanco Animal Health.NEWS8: See what the IHS Markit Score report has to say about Eli Lilly and Co..NEWS9: Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs.NEWS10: Stocks making the biggest moves premarket: Hasbro, Coty, Expedia, Verizon & more.NEWS11: New Research Coverage Highlights Eli Lilly, Newell Brands, Novanta, Carrols Restaurant Group, 8x8, and Quanta Services — Consolidated Revenues, Company Growth, and Expectations for 2019.NEWS12: Eli Lilly to divest remaining stake in Elanco via an exchange offer.NEWS13: Lilly Will Initiate Divestiture of its Remaining Interest in Elanco Animal Health.

Answer: Decrease